Both in Pharmaceuticals
Greenwich LifeSciences vs CAMP4 Therapeutics
Over the past year GLSI returned +106.5% and CAMP returned +0.5%; their daily moves had a correlation of 0.21.
GLSI +106.5% CAMP +0.5%Growth of $1, one year, split-adjusted
| Metric | GLSI | CAMP |
|---|---|---|
| Price | $17.41 | $3.96 |
| Market cap | $255.5M | $248.5M |
| Today | −8.37% | +1.54% |
| 1 month | +0.3% | +3.1% |
| 6 months | −26.5% | −2.2% |
| Year to date | −17.1% | −35.4% |
| 1 year | +90.3% | +2.6% |
| Revenue growth (YoY) | — | +18.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1884.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 58.9× |
| Net cash | $8.9M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 92.1% | 84.1% |
| Short % of float | 24.5% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).